Journal of Jilin University(Medicine Edition) ›› 2024, Vol. 50 ›› Issue (1): 150-160.doi: 10.13481/j.1671-587X.20240119
• Research in clinical medicine • Previous Articles Next Articles
Yaxin LIU1,Jian LIU1,Zhen LI1,Zhanhong CAO1,Haonan BAI1,Yu AN1,Xingyu FANG1,Qing YANG1,Hui LI2(
),Na LI1(
)
Received:2023-02-19
Online:2024-01-28
Published:2024-01-31
Contact:
Hui LI,Na LI
E-mail:doctor_hui@hotmail.com;lhaln@hotmail.com
CLC Number:
Yaxin LIU,Jian LIU,Zhen LI,Zhanhong CAO,Haonan BAI,Yu AN,Xingyu FANG,Qing YANG,Hui LI,Na LI. Inhibitory effect of royal jelly acid on proliferation of human colon cancer SW620 cells and its network pharmacological analysis[J].Journal of Jilin University(Medicine Edition), 2024, 50(1): 150-160.
Tab. 2
Scratch healing rates of cells in various groups"
| Group | Scratch healing rate | ||
|---|---|---|---|
| (t/h) 12 | 24 | 48 | |
| Control | 11.99±0.06 | 24.72±0.06 | 47.98±0.01 |
| 10-HDA | |||
| Low dose | 9.61±0.03* | 13.71±0.04* | 25.62±0.02** |
| Middle dose | 4.43±0.04* | 7.76±0.04* | 8.87±0.04** |
| High dose | 1.64±0.01* | 2.81±0.01** | 5.95±0.03** |
| *P<0.05,**P<0.01 compared with control group. | |||
Tab. 3
Percentages of cells at different cell cycles in various groups"
| Group | Percentage of cells | ||
|---|---|---|---|
| G0/G1 | S | G2/M | |
| Control | 51.37±2.16 | 43.47±0.81 | 5.16±1.44 |
| 10-HDA | |||
| Low dose | 49.92±9.90 | 45.96±9.10 | 4.12±0.57 |
| Middle dose | 43.20±5.14 * | 53.92±1.74 * | 2.88±1.17 |
| High dose | 36.15±0.56 ** | 58.60±0.98 ** | 5.25±1.89 |
| *P<0.05, **P<0.01 compared with control group. | |||
Tab. 4
Activities of T-AOC and SOD in cells in various groups"
| Group | T-AOC [mB/(mmol·g-1)] | SOD [λB/(U·mL-1)] |
|---|---|---|
| Control | 0.37±0.03 | 22.72±0.23 |
| 10-HDA | ||
| Low dose | 0.22±0.02 ** | 15.02±6.03* |
| Middle dose | 0.14±0.02 **△ | 14.10±3.82 **△ |
| High dose | 0.11±0.03 **△ | 10.12±3.30 **△ |
| *P<0.05, **P<0.01 compared with control group; △P<0.05 compared with low dose of 10-HDA group. | ||
| 1 | SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2020[J]. Cancer J Clin, 2020, 70(1): 7-30. |
| 2 | ZHANG X J, LIU Z Z, CHEN S P, et al. A new discovery: total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway[J]. J Ethnopharmacol, 2022, 283: 114742. |
| 3 | 董 梁, 张 敬, 缪 柯. 川芎内酯抑制结肠癌细胞的生长和肿瘤干细胞样特性[J]. 广州中医药大学学报, 2021, 38(12): 2742-2750. |
| 4 | 孙红霞, 刘春旭, 安学俊, 等. 北五味子多糖对人膀胱癌T24细胞增殖和凋亡的影响及其机制[J]. 吉林大学学报(医学版), 2022, 48(5): 1216-1222. |
| 5 | FAN P, SHA F F, MA C, et al. 10-hydroxydec-2-enoic acid reduces hydroxyl free radical-induced damage to vascular smooth muscle cells by rescuing protein and energy metabolism[J]. Front Nutr, 2022, 9: 873892. |
| 6 | ALBALAWI A E, ALTHOBAITI N A, ALRDAHE S S, et al. Anti-tumor effects of queen bee acid (10-hydroxy-2-decenoic acid) alone and in combination with cyclophosphamide and its cellular mechanisms against Ehrlich solid tumor in mice[J]. Molecules, 2021, 26(22): 7021. |
| 7 | JOVANOVIĆ M M, ŠEKLIĆ D S, RAKOBRADOVIĆ J D, et al. Royal jelly and trans-10-hydroxy-2-decenoic acid inhibit migration and invasion of colorectal carcinoma cells[J]. Food Technol Biotechnol, 2022, 60(2): 213-224. |
| 8 | YANG Y C, CHOU W M, WIDOWATI D A, et al. 10-hydroxy-2-decenoic acid of royal jelly exhibits bactericide and anti-inflammatory activity in human colon cancer cells[J]. BMC Complement Altern Med, 2018, 18(1): 202. |
| 9 | 刘晓冉, 朱 娜, 李 辉, 等. 王浆酸的药理作用研究进展[J]. 特产研究, 2020, 42(4): 85-88. |
| 10 | 汪洺卉, 刘墨祎, 王鹤霖, 等. 基于锦灯笼对白血病作用机制的网络药理学和分子对接技术的生物信息学分析[J]. 吉林大学学报(医学版), 2023, 49(1): 74-83. |
| 11 | HAO Y, CHEN Y, HE X, et al. Polymeric nanoparticles with ROS-responsive prodrug and platinum nanozyme for enhanced chemophotodynamic therapy of colon cancer[J].Adv Sci(Weinh),2020,7(20):2001853. |
| 12 | SIEGEL R L, MILLER K D, WAGLE N S, et al. Cancer statistics, 2023[J]. Cancer J Clin, 2023, 73(1): 17-48. |
| 13 | ZHOU J C, ZHENG R S, ZHANG S W, et al. Colorectal cancer burden and trends: comparison between China and major burden countries in the world[J].Chung Kuo Yen Cheng Yen Chiu,2021,33(1): 1-10. |
| 14 | MORII Y, TSUBAKI M, TAKEDA T, et al. Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutation[J]. Eur J Pharmacol, 2021, 898: 173957. |
| 15 | ZHANG C H, CHEN L, BAI Q, et al. Nonmetal graphdiyne nanozyme-based ferroptosis-apoptosis strategy for colon cancer therapy[J]. ACS Appl Mater Interfaces, 2022, 14(24): 27720-27732. |
| 16 | WANG J Y, CHANG H K, SU M, et al. The potential mechanisms of cinobufotalin treating colon adenocarcinoma by network pharmacology[J]. Front Pharmacol, 2022, 13: 934729. |
| 17 | ZHANG Y, CHEN H G, ZHAO C, et al. Research progress on anti-hepatocellular carcinoma mechanism of active ingredients of traditional Chinese medicine[J]. China J Chin Mater Med, 2020, 45(14): 3395-3406. |
| 18 | TSAI P J, LAI Y H, MANNE R K, et al. Akt: a key transducer in cancer[J]. J Biomed Sci, 2022, 29(1): 76. |
| 19 | LI X, ZHAO L, CHEN C, et al. Can EGFR be a therapeutic target in breast cancer?[J]. Biochim Biophys Acta Rev Cancer, 2022, 1877(5): 188789. |
| 20 | 方 翌, 郭旭鸿, 魏丽慧, 等. 八宝丹阻滞人结肠癌细胞周期抑制结肠癌细胞生长[J]. 福建中医药, 2023, 54(1): 25-28. |
| 21 | MA L, LI X, ZHAO X P, et al. Oxaliplatin promotes siMAD2L2‑induced apoptosis in colon cancer cells[J]. Mol Med Rep, 2021, 24(3): 629. |
| 22 | CAI R, ZHOU Y P, LI Y H, et al. Baicalin blocks colon cancer cell cycle and inhibits cell proliferation through miR-139-3p upregulation by targeting CDK16[J]. Am J Chin Med, 2023, 51(1): 189-203. |
| 23 | 胡乃华. 石斛多糖通过改善肠道屏障功能、调节肠道微生物群、减少氧化应激和炎症反应改善右旋糖酐-硫酸钠诱导的小鼠结肠炎[J]. 天然产物研究与开发, 2022, 34(1): 41. |
| 24 | 王继凤, 刘晓冉, 隋 欣, 等. 基于cAMP/PKA/CREB信号通路独参汤对衰老模型大鼠认知功能障碍的影响[J].吉林大学学报(医学版),2021,47(4):865-873. |
| 25 | SUN H N, XIE D P, REN C X,et al. Ethyl β-carboline-3-carboxylate increases cervical cancer cell apoptosis through ROS-p38 MAPK signaling pathway[J]. In Vivo, 2022, 36(3): 1178-1187. |
| 26 | 刘俊秀, 周 佳, 律广富, 等. 参红补血颗粒对气滞血瘀型血管内皮功能障碍小鼠血管内皮的保护作用及其机制[J]. 吉林大学学报(医学版), 2022, 48(6): 1437-1447. |
| 27 | LIU T F, HAN Y W, ZHOU T, et al. Mechanisms of ROS-induced mitochondria-dependent apoptosis underlying liquid storage of goat spermatozoa[J]. Aging, 2019, 11(18): 7880-7898. |
| 28 | TAO S C, LI J Y, WANG H, et al. Anti-colon cancer effects of Dendrobium officinale kimura & migo revealed by network pharmacology integrated with molecular docking and metabolomics studies[J]. Front Med, 2022, 9: 879986. |
| 29 | 陈小忠, 王 培, 谢明祥, 等. 下调SLP-2基因表达抑制脑胶质瘤细胞增殖及诱导凋亡的机制研究[J]. 中国免疫学杂志, 2018, 34(1): 55-59. |
| 30 | LIU A H, ZUO Z F, LIU L L, et al. Down-regulation of NTSR3 inhibits cell growth and metastasis, as well as the PI3K-AKT and MAPK signaling pathways in colorectal cancer[J]. Biochimie Biol Cell, 2020, 98(5): 548-555. |
| 31 | ZHANG C H, LIU H, ZHAO W L, et al. G3BP1 promotes human breast cancer cell proliferation through coordinating with GSK-3β and stabilizing β-catenin[J]. Acta Pharmacol Sin, 2021, 42(11): 1900-1912. |
| 32 | LI K, ZHANG J W, TIAN Y H, et al. The Wnt/β-catenin/VASP positive feedback loop drives cell proliferation and migration in breast cancer[J]. Oncogene, 2020, 39(11): 2258-2274. |
| 33 | SONG Q, HAN Z, WU X, et al. β-Arrestin1 promotes colorectal cancer metastasis through GSK-3β/β-catenin signaling-mediated epithelial-to-mesenchymal transition[J]. Front Cell Dev Biol, 2021, 9: 650067. |
| 34 | ERES N, BELLMUNT J. Regulatory proteins of the cell cycle: alterations in the cycline D1 pathway as a paradigm. Findings in breast cancer[J]. Med Clin, 1998, 111(15): 592-596. |
| [1] | Yang LI,Shiyang LI,Hongmei ZHANG,Qianqian LIU,Yubing CHEN. Effect of NGFR gene expression differences on promotion of apoptosis of squamous cell carcinoma and adenocarcinoma cells by PD-1 inhibitor-activated T lymphocytes [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 680-693. |
| [2] | Qiaotong REN,Weihua WU,Xingxiang WANG,Shichao WANG,Yipeng CHENG,Chun LI. Effect of interleukin-17 recepter B gene silencing on proliferation, invasion and apoptosis of lung adenocarcinoma A549 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 738-745. |
| [3] | Qiuping SU,Lei XING,Wei ZHANG,Shan JIANG,Yangyang ZHAO,Fangfang CHEN. Research progress in anti-tumor mechanism of berberine and application of its novel nano-delivery system in tumor therapy [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 863-871. |
| [4] | Jie YU,Zongkang WANG,Xun LIU,Yanan YANG,Jin TAN. Effect of miR-153-3p/PGC-1α axis on apoptosis of oral squamous cell carcinoma cells by modulation of mitochondrial apoptosis pathway [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 348-358. |
| [5] | Yaping LI,Chunyan TAN,Lujie ZHAO,Jiayi ZHAO,Ting LI,Xiao YANG,Xiaoyun YANG. Inductive effect of lysophosphatidic acid combined with 6-hydroxydopamine on apoptosis of SH-SY5Y cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 152-161. |
| [6] | Jiaxin WANG,Junwen MAO,Xuan ZHANG. Expression of natural autoantibodies against apoptosis inhibitory genes in plasma of patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 228-235. |
| [7] | Huaimin LIANG,Jiacheng JIN,Wenhua CHEN,Yuyao LI,Hangyu WANG,Ke ZHANG,Jinhui WANG. UPLC-Q-TOF/MS and network pharmacology analysis and experimental verification based on potential active ingredients and mechanisms of medicinal Mulberry Leaves in anti-acute kidney injury [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 56-69. |
| [8] | Shanshan SUN,Mei LU,Xinfu GAO,LYu Guangyao,Baolei Zhao,LYu Wenwen. Inhibitory effect of Bradykinin 1 receptor antagonist ELN441958 on proliferation of HepG2 cells by regulating Akt/FoxO3a signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 70-80. |
| [9] | Xiaohan YAO,Mingchen YAO,Zhiqing WANG,Heyang LI,Yan YAN,Ningjing LEI. Effect of silencing GPR139 gene on proliferation, apoptosis and autophagy of breast cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 1-9. |
| [10] | Yu YAN,Dandan HUANG,Chunling HONG,Bowen WEI,Yuanyuan YANG,Guanghai YAN,Yilan SONG,Zhemin XIAN. Improvement effect of imperatorin on airway remodeling in bronchial asthma mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1508-1517. |
| [11] | Pingsheng ZHU,Sitang GE,Lugen ZUO,Deli CHEN,Yangyang ZHANG. Effect of miR-325-3p targeting PRELID1 gene in regulation of EMT pathway on invasion and migration of colon cancer cells and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1185-1193. |
| [12] | Yanhong MU,Yingna LI,Jianzeng LIU,Chunhong LUO,Liwei SUN,Rui JIANG. Promotional effect of CHAaHGS on hair growth and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1240-1250. |
| [13] | Han XUE,Yuxin FAN,Ting ZHANG,Zhimin LI,Mingge HUO,Xingang GUAN. Preparation of nanodrug PTX2 NPs and its killing effect on human lung cancer A549 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1260-1266. |
| [14] | Jiarui LI,Zhenlin YANG,Fan GAO,Jingjing GUO,Jinzi LI. Effect of miR-34a-5p on hippocampal neuron apoptosis in rats with temporal lobe epilepsy and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 939-947. |
| [15] | Panxi SUN,Xue QIN,Chongyang ZHANG,Jia LUO,Yong CHEN,Lili WEI. Protective effect of TUG-891 on ischemic stroke induced by ischemia and hypoxia and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 968-975. |